Belief is outweighing scepticism as nations rush to vaccinate. Indonesia has begun shipping in Chinese-produced shots that have not even completed phase 3 clinical trials. Haste is understandable. Infections, while hard to assess in a populous nation with little testing, appear to be spiralling.
隨著各國競相拿到新型冠狀病毒肺炎(COVID-19,即2019冠狀病毒病)疫苗,人們對疫苗的信心已經勝過了懷疑。印度尼西亞已經開始進口中國生產的疫苗,儘管這些疫苗還沒有完成III期臨牀試驗。印尼的行動如此倉促是可以理解的。這個人口衆多的國家幾乎沒有進行多少檢測,很難評估感染情況,但該國的感染人數似乎正在急劇成長。
您已閱讀14%(453字),剩餘86%(2775字)包含更多重要資訊,訂閱以繼續探索完整內容,並享受更多專屬服務。